DeepNewz, mobile.

People-sourced. AI-powered. Unbiased News.

Screenshot of DeepNewz app showing story detail view.

Screenshot of DeepNewz app showing story list view.

Susvimo News

4D Molecular Therapeutics Shares Rise on 52- and 60-Week 4D-150 Data Showing 78% Injection Reduction, EMA Pathway; Genentech Susvimo Maintains Vision Over 5 Years

4D Molecular Therapeutics Shares Rise on 52- and 60-Week 4D-150 Data Showing 78% Injection Reduction, EMA Pathway; Genentech Susvimo Maintains Vision Over 5 Years

7

2 days ago

Latest stories

Aug 1, 2025
Aug 1, 2025
Stocks
Pharma
Business
4D Molecular Therapeutics Shares Rise on 52- and 60-Week 4D-150 Data Showing 78% Injection Reduction, EMA Pathway; Genentech Susvimo Maintains Vision Over 5 Years
Authors
7
2 days ago

Join our channels

Get the latest stories live on any device.

WhatsApp
Top Stories
Join
Telegram
Top Stories
Join